Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 46
Filter
1.
Int Heart J ; 59(1): 216-219, 2018 Jan 27.
Article in English | MEDLINE | ID: mdl-29332919

ABSTRACT

Aerobic training based on anaerobic threshold (AT) is well-known to improve cardiac function, exercise capacity, and long-term outcomes of patients with heart failure. Recent reports suggested that high-intensity interval training (HIIT) for patients with cardiovascular disease may improve cardiopulmonary exercise capacity. We present a 61-year-old male patient of severe left ventricular dysfunction with left ventricular assisted device (LVAD). Following HIIT for 8 weeks, exercise capacity and muscle strength have improved without worsening left ventricular function. Our case showed the possibility that HIIT was feasible and effective even in patients with LVAD.


Subject(s)
Exercise Therapy/methods , Exercise Tolerance/physiology , Heart-Assist Devices , High-Intensity Interval Training/methods , Ventricular Dysfunction, Left/rehabilitation , Echocardiography , Humans , Male , Middle Aged , Oxygen Consumption/physiology , Severity of Illness Index , Stroke Volume/physiology , Ventricular Dysfunction, Left/diagnosis , Ventricular Dysfunction, Left/physiopathology , Ventricular Function, Left/physiology
2.
Heart Vessels ; 32(11): 1382-1389, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28634694

ABSTRACT

Atrial fibrillation (AF) is one of the most common cardiac arrhythmias, and carries an increased risk of cardiogenic embolism. Oral anticoagulants (OACs) including warfarin and/or non-vitamin K antagonists can prevent the majority of these events. The Saitama AF Registry was a community-based survey of patients with AF in Saitama City, which represents an urban community in Japan. A total of 75 institutions participated in the registry and attempted to enroll consecutive patients with AF from September 2014 to August 2015. The aim of the present study was to examine the clinical characteristics of patients with AF using data of the Saitama AF Registry. In addition, we investigated the difference in clinical characteristics of the patients between small-sized hospitals and large-sized hospitals. A total of 3591 patients were enrolled; 57.7% of all patients were enrolled from small-sized hospitals, whereas 42.3% were from large-sized hospitals. The patients from small-sized hospitals had higher CHADS2 score than those from large-sized hospitals. Approximately, 80% of all patients were treated with OACs, and the prescription rate was higher in patients with CHADS2 score ≥ 2 from both small-sized hospitals and large-sized hospitals. In conclusion, the present study demonstrated an appropriate use of OACs for high-risk patients with CHADS2 score ≥2 in Saitama City regardless of hospital size.


Subject(s)
Anticoagulants/administration & dosage , Atrial Fibrillation/drug therapy , Embolism/epidemiology , Registries , Risk Assessment , Surveys and Questionnaires , Administration, Oral , Aged , Aged, 80 and over , Atrial Fibrillation/complications , Atrial Fibrillation/epidemiology , Embolism/etiology , Embolism/prevention & control , Female , Humans , Japan/epidemiology , Male , Prognosis , Risk Factors
3.
Heart Vessels ; 32(10): 1186-1194, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28466409

ABSTRACT

This multi-center prospective non-randomized comparative study investigated the effects of pitavastatin in patients with peripheral artery disease (PAD) in terms of exercise tolerance capacities and peripheral CD34+/133+ cell numbers. At baseline, a peripheral blood test was administered to 75 patients with PAD, along with a treadmill exercise test using the Skinner-Gardner protocol to measure asymptomatic walking distance (AWD) and maximum walking distance (MWD). Each patient was assigned to a 6-month pitavastatin treatment group (n = 53) or a control group (n = 22), according to the patient's preference. The tests were repeated in both groups at 3 and 6 months. Baseline AWD and MWD correlated positively with the ankle-brachial pressure index (r = 0.342, p = 0.0032 and r = 0.324, p = 0.0054, respectively). Both AWD and MWD values improved at 3 and 6 months compared with baseline, and the degrees of their improvement were higher in the pitavastatin treatment group. CD34+/133+ cell numbers did not change over time or between groups. Eighty-seven percent of patients in the treatment group attained low-density lipoprotein cholesterol levels below 100 mg/dL after 3 months. The study shows that pitavastatin may be effective in increasing exercise tolerance capacity in patients with PAD.


Subject(s)
Exercise Tolerance/drug effects , Peripheral Arterial Disease/drug therapy , Quinolines/administration & dosage , Walking , AC133 Antigen/metabolism , Aged , Aged, 80 and over , Ankle Brachial Index , Antigens, CD34/metabolism , Cell Count , Female , Humans , Japan , Male , Middle Aged , Prospective Studies , Risk Factors , Walk Test
4.
Heart Vessels ; 32(9): 1051-1061, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28396938

ABSTRACT

Postprandial hypertriglyceridemia and hyperglycemia may promote endothelial and hemorheological dysfunction. The present study investigated the effects of pravastatin on endothelial function and hemorheology in patients with stable angina pectoris (AP) before and after eating a test meal. We recruited 26 patients with stable AP who had impaired glucose tolerance and mild dyslipidemia and six healthy men as controls to assess endothelial function and hemorheological behavior. In each group, we measured forearm blood flow (FBF) during post-ischemic reactive hyperemia and obtained blood samples before and 2 h after the test meal. Pravastatin 20 mg/day was then commenced in the 26 AP patients. The above tests were repeated after 2 days and 6 months. Maximum FBF during hyperemia in the baseline fasting phase was significantly lower in the AP patients than in the controls (p < 0.05). Fasting and postprandial FBF during reactive hyperemia time-dependently improved after pravastatin treatment (p < 0.05 vs. baseline data for each phase). Pravastatin treatment for 6 months, but not for 2 days, inhibited leukocyte activation and improved hemorheological parameters. In conclusion, pravastatin treatment for 6 months improved fasting and postprandial endothelial and hemorheological dysfunction in AP patients.


Subject(s)
Angina Pectoris/physiopathology , Endothelium, Vascular/physiopathology , Hemorheology/physiology , Postprandial Period/physiology , Pravastatin/pharmacology , Vasodilation/drug effects , Angina Pectoris/blood , Angina Pectoris/drug therapy , Endothelium, Vascular/drug effects , Female , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Male , Middle Aged , Vasodilation/physiology
5.
Intern Med ; 55(18): 2639-42, 2016.
Article in English | MEDLINE | ID: mdl-27629960

ABSTRACT

A 44-year-old woman, who had been previously diagnosed with coronary spastic angina and treated with standard medical therapy including calcium channel blockers, was admitted to our hospital due to chest pain at rest. Her chest pain attacks were concentrated just before and during menstruation. Despite the administration of an intravenous infusion of nitroglycerin and nicorandil, strong heart attacks with ST elevation occurred frequently after this admission. However, following continuous combined estrogen-progestin hormonal contraception use (estradiol plus dienogest), her attacks disappeared completely. Reduced estrogen levels before and during menstruation were speculated to be associated with her angina attacks.


Subject(s)
Anti-Arrhythmia Agents/therapeutic use , Calcium Channel Blockers/therapeutic use , Chest Pain/physiopathology , Contraceptives, Oral, Combined/therapeutic use , Coronary Vasospasm/physiopathology , Estrogens/therapeutic use , Progestins/therapeutic use , Adult , Chest Pain/drug therapy , Chest Pain/etiology , Coronary Vasospasm/complications , Coronary Vasospasm/drug therapy , Female , Follow-Up Studies , Humans , Infusions, Intravenous , Nicorandil/therapeutic use , Nitroglycerin/administration & dosage , Recurrence , Treatment Outcome
6.
J Cardiol ; 67(6): 555-9, 2016 06.
Article in English | MEDLINE | ID: mdl-26299611

ABSTRACT

BACKGROUND: Compared to transpulmonary pressure gradient (TPPG), diastolic pulmonary vascular pressure gradient (DPG) may be a more sensitive and specific indicator for pulmonary hypertension (PH) due to left heart disease (LHD) with significant pulmonary vascular disease (PVD). The aim of this study was to investigate the incidence and clinical features of PH-LHD with PVD classified by DPG and TPPG. METHODS: We analyzed 410 patients admitted for symptomatic heart failure (HF) (New York Heart Association ≥2) and who underwent right heart catheterization (RHC) at compensated stage between 2007 and 2012. Patients with PH-LHD were divided into 3 groups according to the value of DPG and TPPG (Non-PVD group: DPG <7mmHg and TPPG ≤12mmHg; TPPG-PVD group: DPG <7mmHg and TPPG >12mmHg; DPG-PVD group: DPG ≥7mmHg). Multivariate Cox regression analysis was applied to investigate whether each PH-LHD category predicts death or HF readmission after adjusting for other variables. RESULTS: PH-LHD was observed in 164 patients (40%) with symptomatic HF. Thirteen patients (3%) were allocated into DPG-PVD group, while 24 patients were allocated into TPPG-PVD group (6%). DPG-PVD group was significantly associated with death or HF readmission compared to non-PVD group (hazard ratio: 3.57; 95% CI: 1.33 to 9.55, p=0.01), while the association between TPPG-PVD group and non-PVD group did not reach statistical significance (hazard ratio: 1.89; 95% CI: 0.77 to 4.64, p=0.17). CONCLUSIONS: PH-LHD with PVD classified by DPG was significantly associated with poor long-term clinical outcomes, whereas the association between PH-LHD with PVD classified by TPPG and clinical outcomes did not reach statistical significance. However, further studies are needed, because there was no substantial difference in clinical outcomes between PH-LHD with PVD classified by DPG and PH-LHD with PVD classified by TPPG.


Subject(s)
Heart Failure/complications , Hypertension, Pulmonary/etiology , Pulmonary Circulation/physiology , Cardiac Catheterization , Female , Heart Failure/physiopathology , Humans , Hypertension, Pulmonary/physiopathology , Male , Middle Aged , Prognosis , Proportional Hazards Models , Pulmonary Artery/physiopathology , Vascular Diseases/complications , Vascular Diseases/physiopathology
7.
Intern Med ; 54(16): 2025-8, 2015.
Article in English | MEDLINE | ID: mdl-26278296

ABSTRACT

Diabetic ketoacidosis (DKA) is one of the most serious acute complications of diabetes mellitus. An arterial thrombotic tendency from DKA is relatively common; however, the occurrence of acute multiple arteriovenous thromboses is rare. We herein report the case of a 49-year-old man with DKA complicated by multiple thromboses. After transfer to our emergency room with DKA, the patient developed sudden abdominal pain. Contrast-enhanced computed tomography revealed near-complete occlusion of the superior mesenteric artery, superior mesenteric vein, splenic artery, and right femoral artery. This occurrence highlights the need for considering the risk of thrombosis during the initial treatment for DKA.


Subject(s)
Abdominal Pain/surgery , Diabetic Ketoacidosis/surgery , Mesenteric Veins/pathology , Portal Vein/pathology , Thrombosis/surgery , Abdominal Pain/diagnostic imaging , Abdominal Pain/etiology , Anticoagulants/administration & dosage , Diabetic Ketoacidosis/complications , Heparin/administration & dosage , Humans , Male , Mesenteric Veins/diagnostic imaging , Middle Aged , Portal Vein/diagnostic imaging , Radiography , Thrombosis/complications , Thrombosis/diagnostic imaging , Treatment Outcome
8.
Int Heart J ; 56(3): 324-8, 2015 May 13.
Article in English | MEDLINE | ID: mdl-25902880

ABSTRACT

Acute aortic dissection (AAD) is a life-threatening cardiovascular disease with high mortality. Hypertension is a well known risk factor of AAD. There have been previous reports about the association between circadian variation of blood pressure (BP) and cardiovascular events. However, little is known about the association between the onset-time of AAD and circadian variation of BP. The purpose of this study was to clarify the characteristics of circadian variation of BP in AAD and its relation to the onset-time of this disease. This study included type B spontaneous AAD patients who were referred to our institution and treated conservatively between January 2008 and June 2013. Patients with type A AAD, secondary to trauma, and type B AAD which preceded surgical intervention were excluded. Data were retrospectively collected from the hospital medical records. Sixty-eight patients with type B AAD were enrolled. The distribution of the circadian pattern in the study patients was as follows: extreme-dipper, 0% (none); dipper, 20.6% (n = 14); nondipper, 50% (n = 34); riser, 29.4% (n = 20). Non-dipper and riser patterns were more frequently observed compared with other population studies reported previously. Moreover, no patient in the dipper group had night-time onset while 31.5% of the patients in the absence of nocturnal BP fall group (non-dipper and riser) did (P = 0.01). Absence of a nocturnal BP fall was frequently seen in AAD patients. Absence of a nocturnal BP fall may be a risk factor of AAD. Circadian variation of BP may also affect the onset-time of type B AAD.


Subject(s)
Aortic Aneurysm/physiopathology , Aortic Dissection/physiopathology , Blood Pressure/physiology , Circadian Rhythm , Acute Disease , Environmental Monitoring , Female , Humans , Male , Middle Aged , Retrospective Studies
9.
J Cardiol ; 64(5): 334-8, 2014 Nov.
Article in English | MEDLINE | ID: mdl-24802171

ABSTRACT

BACKGROUND: The perioperative risk of non-cardiac surgery (NCS) in the patients on antiplatelet therapy after percutaneous coronary intervention (PCI) remains unclear. METHODS: This study was a retrospective and single center study. Between January 2008 and December 2011, 198 patients who had already received PCI underwent NCS in our hospital. Among them, 63 patients underwent surgery on dual antiplatelet therapy (DAPT group) and 88 patients on single antiplatelet therapy (SAPT group). We compared bleeding events and cardiovascular events during perioperative period between the two groups. RESULTS: There was no stent thrombosis in either group. The bleeding events in the DAPT group were significantly higher than that in the SAPT group (9.5% vs 2.3%, p=0.049). There was no difference in events between with or without heparin-bridge in the SAPT group. CONCLUSIONS: The frequency of bleeding events was higher in the DAPT group. Both bleeding and cardiovascular events with aspirin alone were low in our study. It may be safe to undergo NCS with SAPT after PCI.


Subject(s)
Cardiovascular Diseases/chemically induced , Hemorrhage/chemically induced , Percutaneous Coronary Intervention , Perioperative Care/adverse effects , Platelet Aggregation Inhibitors/adverse effects , Stents/adverse effects , Aged , Aspirin/administration & dosage , Aspirin/adverse effects , Cardiovascular Diseases/epidemiology , Female , Hemorrhage/epidemiology , Heparin/administration & dosage , Heparin/adverse effects , Humans , Male , Membrane Proteins , Middle Aged , Perioperative Period , Platelet Aggregation Inhibitors/administration & dosage , Retrospective Studies , Time Factors , Tumor Suppressor Proteins
10.
J Cardiol ; 63(2): 145-8, 2014 Feb.
Article in English | MEDLINE | ID: mdl-23906529

ABSTRACT

BACKGROUND: The circumstances surrounding infective endocarditis (IE) are under constant change due to an increase in drug-resistant organisms, a decrease in rheumatic valve disease, progress in surgical treatment, and aging society. The purpose of this study was to compare clinical features of IE between the 1990s and 2000s and to elucidate the determinants of death or clinical event. METHODS: All hospital admission records between January 1990 and December 2009 were retrospectively analyzed. The definition of IE was based on modified Duke criteria. Clinical presentation, blood culture, laboratory results, and echocardiography findings were compared between the 1990s and 2000s. RESULTS: There were 112 patients with definite or probable IE according to modified Duke criteria. The most frequent organism causing IE was Streptococcus viridians both in the 1990s and 2000s. The determinants of in-hospital death were hemodialysis and congestive heart failure. The in-hospital mortality of IE was 5.4% in the 1990s and 13.3% in the 2000s. Composite events of in-hospital death and central nervous system disorders were significantly higher in the 2000s compared with the 1990s. CONCLUSION: The most frequent causative organism of IE was S. viridians, both in the 1990s and 2000s. Independent predictors of in-hospital mortality in IE were hemodialysis and congestive heart failure.


Subject(s)
Endocarditis/microbiology , Endocarditis/mortality , Viridans Streptococci/isolation & purification , Adult , Age Factors , Aged , Female , Forecasting , Heart Failure , Hospital Mortality , Humans , Male , Methicillin Resistance , Middle Aged , Multivariate Analysis , Renal Dialysis , Retrospective Studies , Time Factors , Viridans Streptococci/pathogenicity
11.
Cardiovasc Diabetol ; 12: 11, 2013 Jan 09.
Article in English | MEDLINE | ID: mdl-23302066

ABSTRACT

BACKGROUND: Osteoprotegerin is a member of the tumor necrosis factor-related family and inhibits RANK stimulation of osteoclast formation as a soluble decoy receptor. The goal of this study was to determine the relationship of serum osteoprotegerin with vascular calcification in patients with type 2 diabetes. METHODS: The subjects were 124 patients with type 2 diabetes mellitus, including 88 males and 36 females with a mean (± SD) age of 65.6 ± 8.2 years old. Serum levels of osteoprotegerin, osteocalcin, fibroblast growth factor 23 (FGF23), 25-hydroxyvitamin D3 and adiponectin were measured by ELISA. Vascular calcification in the cervical artery was examined by ultrasound sonography. The subjects were divided into 4 quartiles depending on serum osteoprotegerin levels. RESULTS: Vascular calcification was significantly higher in the 4th quartile and significantly lower in the 1st quartile of serum osteoprotegerin levels, compared to other quartiles. There were no differences in serum osteoprotegerin and vascular calcification among patients with different stages of diabetic nephropathy, but serum FGF23 levels were elevated in those with stage 4 diabetic nephropathy. Simple regression analysis showed that serum osteoprotegerin levels had significant positive correlations with age, systolic blood pressure and serum adiponectin levels, and significant negative correlations with BMI and serum 25-hydroxyvitamin D3. CONCLUSIONS: These findings suggest that elevated serum osteoprotegerin may be involved in vascular calcification independently of progression of diabetic nephropathy in patients with type 2 diabetes.


Subject(s)
Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/epidemiology , Osteoprotegerin/blood , Vascular Calcification/blood , Vascular Calcification/epidemiology , Adult , Aged , Aged, 80 and over , Biomarkers/blood , Diabetes Mellitus, Type 2/diagnosis , Female , Fibroblast Growth Factor-23 , Humans , Male , Middle Aged , Osteoprotegerin/biosynthesis , Up-Regulation/physiology , Vascular Calcification/diagnosis
12.
Heart Vessels ; 28(1): 86-90, 2013 Jan.
Article in English | MEDLINE | ID: mdl-22203407

ABSTRACT

Fulminant myocarditis is a rapidly progressive, life-threatening disease with severe impairment of systolic left ventricle function in the acute phase. However, the long-term prognosis of patients who survive the acute phase with percutaneous extracorporeal cardiopulmonary support (PCPS) is not established. The purpose of this study was to elucidate the long-term follow-up on chronic cardiac function and long-term outcome. Twenty consecutive patients with fulminant myocarditis in the acute phase supported by PCPS were enrolled between January 1995 and March 2010. Echocardiography was performed at least three times; acute phase (within 3 days from onset), predischarge (days 3-30), and chronic phase (>6 months, 2.67 ± 2.19 years, mean ± SD). The clinical events were queried by their medical record and questionnaires. Eight patients (40%) died in the acute phase. The time course of ejection fraction (%) by echocardiography was 22.7 ± 9.8, 53.1 ± 7.2, and 57.2 ± 9.6 in acute, predischarge, and chronic phase, respectively. Diastolic dimension (mm) was 46.8 ± 7.4, 51.3 ± 2.9, and 50.4 ± 1.8, and systolic dimension (mm) was 41.4 ± 7.7, 36.8 ± 4.0, and 35.2 ± 3.3 in acute, predischarge, and chronic phase, respectively. There was no recurrence or admission related to heart failure during the follow-up period. The cardiac function of patients with fulminant myocarditis recovers rapidly during their stay in hospital. The cardiac function of predischarge patients remains unchanged in the chronic phase. The long-term survival of fulminant myocarditis appears favorable in the chronic phase.


Subject(s)
Extracorporeal Circulation/methods , Myocarditis/physiopathology , Ventricular Function, Left/physiology , Acute Disease , Adolescent , Adult , Aged , Aged, 80 and over , Disease Progression , Echocardiography , Female , Follow-Up Studies , Humans , Male , Middle Aged , Myocarditis/diagnostic imaging , Myocarditis/therapy , Prognosis , Retrospective Studies , Time Factors , Treatment Outcome , Young Adult
13.
Heart Vessels ; 28(6): 677-83, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23089891

ABSTRACT

Left ventricular apical aneurysm (LVAA) is a serious complication of acute anterior myocardial infarction (MI). The purpose of our study was to investigate the clinical features of LVAA in the primary PCI era. A total of 161 acute anterior MI patients who had primary PCI and had an echocardiogram on chronic phase were included. The development of LVAA was reviewed on chronic phase. Univariate and multivariate logistic regression analyses were performed to identify the predictors of LVAA. Primary stenting was performed in 160 patients (99.4 %). Procedural success was obtained in all patients with a final TIMI flow grade 3 obtained in 142 patients (88.2 %). LVAA developed in the chronic phase in 29 patients (18.0 %). Multivariate logistic regression analysis revealed that peak CK (500 mU/ml increase; OR 1.24, 95 % CI 1.09-1.41, p = 0.001), heart rate at discharge (5/min increase; OR 1.39, 95 % CI 1.03-1.87, p = 0.03), final TIMI flow grade ≤2 (vs. TIMI 3; OR 6.95, 95 % CI 1.70-28.36, p = 0.01) and final myocardial brush grade (MBG) ≤2 (vs. MBG 3; OR 4.33, 95 % CI 1.06-17.66, p = 0.04) were significantly associated with the development of LVAA. The initial TIMI flow grade or the grade of collateral flow was not associated with LVAA. In conclusion, peak CK, heart rate, and final TIMI flow grade or final MBG ≤2 were significantly associated with the development of LVAA. Achieving a TIMI flow grade 3 by primary PCI may be important for preventing LVAA.


Subject(s)
Anterior Wall Myocardial Infarction/therapy , Heart Aneurysm/prevention & control , Percutaneous Coronary Intervention , Aged , Anterior Wall Myocardial Infarction/blood , Anterior Wall Myocardial Infarction/complications , Anterior Wall Myocardial Infarction/diagnosis , Anterior Wall Myocardial Infarction/physiopathology , Biomarkers/blood , Coronary Circulation , Creatine Kinase/blood , Female , Heart Aneurysm/diagnosis , Heart Aneurysm/etiology , Heart Aneurysm/physiopathology , Heart Rate , Humans , Logistic Models , Male , Middle Aged , Multivariate Analysis , Odds Ratio , Percutaneous Coronary Intervention/adverse effects , Retrospective Studies , Risk Factors , Time Factors , Treatment Outcome
14.
J Cardiol Cases ; 7(6): e181-e183, 2013 Jun.
Article in English | MEDLINE | ID: mdl-30533158

ABSTRACT

Intravascular lymphomatosis (IVL) is a rare subtype of lymphoma characterized by proliferation of lymphoma cells into small vessels. Clinical presentations of IVL are considerably varied among patients, and antemortem diagnosis is sometimes difficult. We report a 75-year-old Japanese female who presented with gradually worsening shortness of breath and pulmonary hypertension. After routine examinations, the patient was diagnosed with pulmonary artery hypertension (PH) combined with pulmonary hypertension owing to left-sided heart disease possibly due to chronic atrial fibrillation. However, a standard therapy of PH and diuretics was ineffective. In the clinical course, sustained increase in serum lactate dehydrogenase level, progressive bicytopenia, and appearance of atypical cells in her peripheral blood led to the diagnosis of IVL. The symptoms, laboratory findings and PH improved after initial chemotherapy. .

15.
Endocr J ; 59(12): 1085-91, 2012.
Article in English | MEDLINE | ID: mdl-22863748

ABSTRACT

The present study was undertaken to determine whether acute exercise load alters serum retinol-binding protein 4 (RBP4) and numbers of endothelial progenitor cells (EPC) in diabetic subjects. Sixty-two subjects with type 2 diabetes mellitus were enrolled in the present study. They were 50 males and 12 females with the ages of 65.1±8.1 (mean ± SD) years. Cardio-pulmonary exercise stress test (CPX) was carried out, and the numbers of EPC and serum RBP4 levels before and after the CPX were measured. RBP4 is a cytokine synthesized in hepatocytes, white adipose tissues and skeletal muscles, and serum RBP4 was determined by ELISA. EPC was determined as CD34(+)/133(+) cells by FACS. The subjects were subgrouped into two groups with or without nephropathy. Serum RBP4 levels promptly increased from 48.2±4.3 (mean±SEM) to 54.3±4.2 µg/mL after the CPX (mean exercise time of 8 min) in the diabetic subjects without nephropathy (p=0.0006), but did not in those with nephropathy. There was a positive correlation between changes in serum RBP4 during the exercise and estimated glomerular filtration rate (r=0.30, p=0.018). Also, an acute exercise load promptly increased the number of EPCs in the diabetic subjects with and without nephropathy. These findings suggest that a prompt increase in exercise-induced RBP4 is retarded by progression of nephropathy, and that an exercise-induced mobilization of EPCs could maintain endothelial cells in diabetic subjects.


Subject(s)
Diabetes Mellitus, Type 2/metabolism , Diabetes Mellitus, Type 2/pathology , Endothelial Cells/pathology , Exercise/physiology , Retinol-Binding Proteins, Plasma/metabolism , Aged , Cell Count , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/complications , Diabetic Nephropathies/blood , Diabetic Nephropathies/metabolism , Disease Progression , Endothelial Cells/physiology , Exercise Test , Female , Humans , Male , Middle Aged , Stem Cells/pathology , Stem Cells/physiology , Up-Regulation , Workload
16.
J Cardiol ; 60(4): 306-9, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22727629

ABSTRACT

BACKGROUND: Temporary vena cava filters have been used for protection from potentially fatal pulmonary embolism. However, recent reports suggested that they may be associated with serious adverse complications including filter-related thrombosis. The purpose of this study was to examine the clinical complications of temporary vena cava filter placement. METHODS: We enrolled 40 consecutive patients from January 2006 to December 2010 who underwent percutaneous temporary vena cava filter insertion in Saitama Medical Center, Jichi Medical University. RESULTS: Major filter complications related to temporary vena cava filters were filter thrombosis in 4 patients (10.2%), filter dislocation in 4 (10.2%), and catheter-related infection in 3 (7.7%). Massive pulmonary embolism and cardiogenic shock was observed in one case (2.5%) at the time of retraction. CONCLUSION: Temporary filter placement was associated with a high incidence of device-related complications. The benefit of temporary filter placement should be judiciously weighed against the risk of complications.


Subject(s)
Thrombosis/etiology , Vena Cava Filters/adverse effects , Equipment Failure , Female , Humans , Male , Middle Aged , Pulmonary Embolism/etiology , Retrospective Studies
17.
J Cardiol ; 59(2): 215-9, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22266459

ABSTRACT

BACKGROUND: Little has been known about clinical features and prognosis of very old patients with heart failure with preserved ejection fraction (HFPEF). The aim of this study was to compare clinical features and clinical outcomes between HFPEF and heart failure with reduced ejection fraction (HFREF) in patients older than 80 years. METHODS: We enrolled a total of 113 patients over 80 years old, who were admitted for heart failure between 2006 and 2009. We retrospectively analyzed the clinical features including laboratory data and echocardiography parameters. RESULTS: In 53 patients (49%) left ventricular ejection fraction was preserved. The clinical characteristics and treatment between HFPEF and HFREF showed that anemia was one of the risk factors for HFPEF, and the long-term outcomes of HFPEF in this population were not different from that of HFREF. CONCLUSION: These results suggest that anemia is one of the important risk factors for HFPEF in the very elderly.


Subject(s)
Heart Failure/physiopathology , Stroke Volume/physiology , Age Factors , Aged, 80 and over , Anemia/complications , Female , Humans , Male , Retrospective Studies , Risk Factors
18.
Heart Vessels ; 27(5): 475-9, 2012 Sep.
Article in English | MEDLINE | ID: mdl-21842264

ABSTRACT

Ventricular septal perforation (VSP) is a serious complication associated with acute myocardial infarction (MI). The purpose of this study was to investigate the determinants of in-hospital death in patients with postinfarction VSP. Between January 1990 and April 2010, we identified 37 patients from our hospital records. Univariate analysis and multivariate logistic regression analysis were performed to find the determinants of in-hospital death. In-hospital mortality was 35% (13/37 patients). History of hypertension (P = 0.03), percutaneous coronary intervention (P = 0.04), and preoperative percutaneous cardiopulmonary support (P = 0.04) were associated with in-hospital death, whereas history of hyperlipidemia was associated with in-hospital survival. The interval from MI to VSP in survivors was significantly longer than that in nonsurvivors (P < 0.01). In multivariate logistic regression analysis, a shorter interval from MI to VSP (odds ratio 0.57, 95% confidence interval 0.34-0.95, P = 0.03) was found to be an independent predictor of in-hospital death. In conclusion, in-hospital mortality was high in patients with postinfarction VSP. A shorter interval from MI to VSP was a significant independent predictor of in-hospital death.


Subject(s)
Risk Assessment/methods , Ventricular Septal Rupture/mortality , Aged , Cause of Death/trends , Confidence Intervals , Female , Follow-Up Studies , Hospital Mortality/trends , Humans , Japan/epidemiology , Male , Myocardial Infarction/complications , Myocardial Infarction/mortality , Odds Ratio , Retrospective Studies , Risk Factors , Ventricular Septal Rupture/etiology
19.
J Diabetes Investig ; 3(6): 526-33, 2012 Dec 20.
Article in English | MEDLINE | ID: mdl-24843618

ABSTRACT

AIMS/INTRODUCTION: The present study was undertaken to determine vascular endothelial impairment and endothelial progenitor cells (EPCs) in patients with type 2 diabetes mellitus and erectile dysfunction (ED). MATERIALS AND METHODS: A total of 100 type 2 diabetic men were enrolled. Flow-mediated dilatation (FMD) and anaerobic threshold (AT) were measured. Also, EPCs in the peripheral blood were determined by flow cytometry. RESULTS: In the 42 ED diabetic patients, FMD and AT were significantly less than those in the 58 patients with normal erectile function (FMD 2.84 vs 3.82%, P = 0.038, and AT 11.2 vs 12.7 mL/kg/min, P = 0.022). Exercise tolerance significantly increased the number of EPCs in the patients with and without ED (49-60 cells/100 µL, P = 0.015, and 72-99 cells/100 µL, P = 0.003). In the diabetic patients without autonomic neuropathy, FMD was significantly reduced in the patients with ED than those without ED (P = 0.015). In response to exercise tolerance, the number of EPCs increased in both the diabetic patients with ED (P = 0.003) and without ED (P = 0.007). In contrast, in the diabetic patients with autonomic neuropathy, there was no difference in FMD between the patients with and without ED. The exercise tolerance increased the number of EPCs in the patients without ED (P = 0.023), but it disappeared in those with ED. CONCLUSIONS: ED diabetic patients have endothelial impairment during the early period of diabetic complications, whose deranged endothelial function is concomitantly repaired by promoting bone marrow-derived EPCs.

20.
J Cardiol ; 59(1): 78-83, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22071482

ABSTRACT

BACKGROUND: Hemodialysis (HD) is an important risk factor for progression of aortic valve stenosis (AS). However, there are varying degrees of disease progression among patients with AS on HD. The aim of this study was to find determinants of rapid progression of AS in patients on HD. METHODS: We enrolled 30 patients with AS on HD with a mean follow-up period of 4 years. The peak pressure gradient (PPG) between the initial echocardiography and the last echocardiography at least 3 months interval (ΔPPG) was adopted as the indicator of AS progression. We divided the patients into two groups according to ΔPPG per year [rapid progression (ΔPPG>4.5 mmHg/year), slow progression (ΔPPG<4.5 mmHg/year)] and compared the clinical characteristics between the two groups. RESULTS: Overall mean ΔPPG was 4.5 mmHg/year. Systolic blood pressure (SBP), serum calcium, and calcium-phosphate product were significantly higher in rapid progression group compared with slow progression group (p<0.05). CONCLUSION: High systolic blood pressure, serum calcium, and calcium-phosphate product were associated with rapid progression of AS in patients on chronic HD.


Subject(s)
Aortic Valve Stenosis/physiopathology , Renal Dialysis , Aged , Aortic Valve Stenosis/diagnostic imaging , Blood Pressure , Calcium/blood , Calcium Phosphates/blood , Disease Progression , Echocardiography , Female , Follow-Up Studies , Humans , Male , Risk Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...